These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21090730)

  • 1. Synthesis of oxazolo[4,5-c]quinoline TRPV1 antagonists.
    Voight EA; Daanen JF; Kort ME
    J Org Chem; 2010 Dec; 75(24):8713-5. PubMed ID: 21090730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonists.
    Perner RJ; Koenig JR; Didomenico S; Gomtsyan A; Schmidt RG; Lee CH; Hsu MC; McDonald HA; Gauvin DM; Joshi S; Turner TM; Reilly RM; Kym PR; Kort ME
    Bioorg Med Chem; 2010 Jul; 18(13):4821-9. PubMed ID: 20570528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Tetrahydroquinolinyl, N-quinolinyl and N-isoquinolinyl biaryl carboxamides as antagonists of TRPV1.
    Westaway SM; Chung YK; Davis JB; Holland V; Jerman JC; Medhurst SJ; Rami HK; Stemp G; Stevens AJ; Thompson M; Winborn KY; Wright J
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4533-6. PubMed ID: 16806913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A concise synthesis of substituted thiourea derivatives in aqueous medium.
    Maddani MR; Prabhu KR
    J Org Chem; 2010 Apr; 75(7):2327-32. PubMed ID: 20201494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of structure-activity relationships for the 'B-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists.
    Lee J; Jin MK; Kang SU; Kim SY; Lee J; Shin M; Hwang J; Cho S; Choi YS; Choi HK; Kim SE; Suh YG; Lee YS; Kim YH; Ha HJ; Toth A; Pearce LV; Tran R; Szabo T; Welter JD; Lundberg DJ; Wang Y; Lazar J; Pavlyukovets VA; Morgan MA; Blumberg PM
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4143-50. PubMed ID: 15993063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists.
    Blum CA; Caldwell T; Zheng X; Bakthavatchalam R; Capitosti S; Brielmann H; De Lombaert S; Kershaw MT; Matson D; Krause JE; Cortright D; Crandall M; Martin WJ; Murphy BA; Boyce S; Jones AB; Mason G; Rycroft W; Perrett H; Conley R; Burnaby-Davies N; Chenard BL; Hodgetts KJ
    J Med Chem; 2010 Apr; 53(8):3330-48. PubMed ID: 20307063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-substituted N-(4-tert-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as potent and stereospecific TRPV1 antagonists.
    Chung JU; Kim SY; Lim JO; Choi HK; Kang SU; Yoon HS; Ryu H; Kang DW; Lee J; Kang B; Choi S; Toth A; Pearce LV; Pavlyukovets VA; Lundberg DJ; Blumberg PM
    Bioorg Med Chem; 2007 Sep; 15(18):6043-53. PubMed ID: 17629487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.
    Norman MH; Zhu J; Fotsch C; Bo Y; Chen N; Chakrabarti P; Doherty EM; Gavva NR; Nishimura N; Nixey T; Ognyanov VI; Rzasa RM; Stec M; Surapaneni S; Tamir R; Viswanadhan VN; Treanor JJ
    J Med Chem; 2007 Jul; 50(15):3497-514. PubMed ID: 17585749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
    Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heteroaryl beta-tetralin ureas as novel antagonists of human TRPV1.
    Jetter MC; Youngman MA; McNally JJ; McDonnell ME; Zhang SP; Dubin AE; Nasser N; Codd EE; Flores CM; Dax SL
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6160-3. PubMed ID: 17892935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of structure-activity relationships for the 'A-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonists.
    Lee J; Kang SU; Kil MJ; Shin M; Lim JO; Choi HK; Jin MK; Kim SY; Kim SE; Lee YS; Min KH; Kim YH; Ha HJ; Tran R; Welter JD; Wang Y; Szabo T; Pearce LV; Lundberg DJ; Toth A; Pavlyukovets VA; Morgan MA; Blumberg PM
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4136-42. PubMed ID: 16005215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPing the switch on pain: an introduction to the chemistry and biology of capsaicin and TRPV1.
    Conway SJ
    Chem Soc Rev; 2008 Aug; 37(8):1530-45. PubMed ID: 18648679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of benzamide derivatives as TRPV1 antagonists.
    Shishido Y; Jinno M; Ikeda T; Ito F; Sudo M; Makita N; Ohta A; Iki-Taki A; Ohmi T; Kanai Y; Tamura T; Shimojo M
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1072-8. PubMed ID: 18155908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New 1,3-oxazolo[4,5-c]quinoline derivatives: synthesis and evaluation of antibacterial and antituberculosis properties.
    Eswaran S; Adhikari AV; Ajay Kumar R
    Eur J Med Chem; 2010 Mar; 45(3):957-66. PubMed ID: 20034708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterocycle-linked phenylbenzyl amides as novel TRPV1 antagonists and their TRPV1 binding modes: constraint-induced enhancement of in vitro and in vivo activities.
    Kim NJ; Li FN; Lee JH; Park SG; Kim K; Lim C; Han YT; Yun H; Jung JW; Park HG; Kim HD; Woo BY; Shin SS; Kim SY; Choi JK; Jeong YS; Park Y; Park YH; Kim DD; Choi S; Suh YG
    Chem Asian J; 2013 Feb; 8(2):400-9. PubMed ID: 23208797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1.
    Westaway SM; Thompson M; Rami HK; Stemp G; Trouw LS; Mitchell DJ; Seal JT; Medhurst SJ; Lappin SC; Biggs J; Wright J; Arpino S; Jerman JC; Cryan JE; Holland V; Winborn KY; Coleman T; Stevens AJ; Davis JB; Gunthorpe MJ
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5609-13. PubMed ID: 18809327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of piperidine carboxamide TRPV1 antagonists.
    Cheung WS; Calvo RR; Tounge BA; Zhang SP; Stone DR; Brandt MR; Hutchinson T; Flores CM; Player MR
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4569-72. PubMed ID: 18662879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chroman and tetrahydroquinoline ureas as potent TRPV1 antagonists.
    Schmidt RG; Bayburt EK; Latshaw SP; Koenig JR; Daanen JF; McDonald HA; Bianchi BR; Zhong C; Joshi S; Honore P; Marsh KC; Lee CH; Faltynek CR; Gomtsyan A
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1338-41. PubMed ID: 21315587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1.
    Gavva NR; Tamir R; Klionsky L; Norman MH; Louis JC; Wild KD; Treanor JJ
    Mol Pharmacol; 2005 Dec; 68(6):1524-33. PubMed ID: 16135784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Methylated simplified resiniferatoxin (sRTX) thiourea analogues as potent and stereospecific TRPV1 antagonists.
    Kim HS; Jin MK; Kang SU; Lim JO; Tran PT; Hoang VH; Ann J; Ha TH; Pearce LV; Pavlyukovets VA; Blumberg PM; Lee J
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2685-8. PubMed ID: 24794110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.